{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:09:20Z","timestamp":1791036560985,"version":"4.1.0"},"reference-count":26,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.3892\/ijo.2012.1501","type":"journal-article","created":{"date-parts":[[2012,5,31]],"date-time":"2012-05-31T06:07:25Z","timestamp":1338444445000},"page":"565-572","source":"Crossref","is-referenced-by-count":19,"title":["The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma"],"prefix":"10.3892","volume":"41","author":[{"given":"TOYOKO","family":"HARADA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KOJI","family":"HARADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOSHIYA","family":"UEYAMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,5,31]]},"reference":[{"key":"key20180107184800_b1-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.oraloncology.2006.11.012","article-title":"Squamous cell carcinomas arising from different types of oral epithelia differ in their tumor and patient characteristics and survival","volume":"43","author":"Rautava","year":"2007","journal-title":"Oral Oncol"},{"key":"key20180107184800_b2-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hed.10004","article-title":"Presentation, treatment, and outcome of oral cavity cancer: a national cancer data base report","volume":"24","author":"Funk","year":"2002","journal-title":"Head Neck"},{"key":"key20180107184800_b3-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.tripleo.2008.02.030","article-title":"The use of an oral brush biopsy without computer-assisted anaylsis in the oral lesions: a study of 94 patients","volume":"106","author":"Mehrotra","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"key20180107184800_b4-ijo-41-02-0565","first-page":"187","article-title":"Intra-oral squamous cell carcinoma in Ibadan: a review of 90 cases","volume":"26","author":"Lawoyin","year":"1997","journal-title":"Afr J Med Med Sci"},{"key":"key20180107184800_b5-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0040-4039(00)90667-1","article-title":"Synthesis of dl-cepharanthine","volume":"13","author":"Tomita","year":"1967","journal-title":"Tetrahedron Lett"},{"key":"key20180107184800_b6-ijo-41-02-0565","first-page":"2587","article-title":"Clinical effects of cepharanthine (Ceph.) on leukopenia by chemotherapy in lung cancer patients","volume":"24","author":"Saito","year":"1989","journal-title":"Nihon Gan Chiryo Gakkai Shi"},{"key":"key20180107184800_b7-ijo-41-02-0565","first-page":"1061","article-title":"Antitumor effect of cepharanthine: activation of regional lymph node lymphocytes by intratumoral administration","volume":"19","author":"Ono","year":"1987","journal-title":"Clin Immunol"},{"key":"key20180107184800_b8-ijo-41-02-0565","first-page":"1470","article-title":"Synergistic activation of rat alveolar macrophages by cepharanthine and OK-432","volume":"12","author":"Morioka","year":"1985","journal-title":"Gan To Kagaku Ryoho"},{"key":"key20180107184800_b9-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/02656739509004945","article-title":"Effects of hyperthermia and cepharanthine on adriamycin accumulation with change in extracellular pH","volume":"11","author":"Asaumi","year":"1995","journal-title":"Int J Hyperthermia"},{"key":"key20180107184800_b10-ijo-41-02-0565","first-page":"3617","article-title":"Influence of cepharanthine on the intracelluar accumulation of adriamycin in normal liver cells and spleen cells of mice in vitro and in vivo","volume":"17","author":"Nishikawa","year":"1997","journal-title":"Anticancer Res"},{"key":"key20180107184800_b11-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000227680","article-title":"Modulation of multidrug resistance by cepharanthine in fresh human gastrointestinal tumor cells","volume":"54","author":"Hotta","year":"1997","journal-title":"Oncology"},{"key":"key20180107184800_b12-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0304-3835(96)04358-3","article-title":"Synergistic effects of tamoxifen and cepharanthine for circumventing the multidrug resistance","volume":"107","author":"Hotta","year":"1996","journal-title":"Cancer Lett"},{"key":"key20180107184800_b13-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1358\/mf.1998.20.2.485636","article-title":"Cepharanthine inhibits proliferation of cancer cells by inducing apoptosis","volume":"20","author":"Furusawa","year":"1998","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"key20180107184800_b14-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1368-8375(00)00125-1","article-title":"Characteristics of antitumour activity of cepharanthin against a human adenosquamous cell carcinoma cell line","volume":"37","author":"Harada","year":"2001","journal-title":"Oral Oncol"},{"key":"key20180107184800_b15-ijo-41-02-0565","first-page":"1441","article-title":"Cepharanthine exerts antitumor activity on oral squamous cell carcinoma cell lines by induction of p27Kip1","volume":"23","author":"Harada","year":"2003","journal-title":"Anticancer Res"},{"key":"key20180107184800_b16-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3892\/ijo_00000417","article-title":"Cepharanthine inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing expression of vascular endothelial growth factor and interleukin-8","volume":"35","author":"Harada","year":"2009","journal-title":"Int J Oncol"},{"key":"key20180107184800_b17-ijo-41-02-0565","first-page":"1263","article-title":"Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice","volume":"29","author":"Harada","year":"2009","journal-title":"Anticancer Res"},{"key":"key20180107184800_b18-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.dnarep.2006.05.026","article-title":"Role of non- homologous end joining (NHEJ) in maintaining genomic integrity","volume":"5","author":"Burma","year":"2006","journal-title":"DNA Repair (Amst)"},{"key":"key20180107184800_b19-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cell.2005.12.030","article-title":"Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly","volume":"124","author":"Buck","year":"2006","journal-title":"Cell"},{"key":"key20180107184800_b20-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cell.2005.12.031","article-title":"XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining","volume":"124","author":"Ahnesorg","year":"2006","journal-title":"Cell"},{"key":"key20180107184800_b21-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"13857","DOI":"10.1074\/jbc.C500473200","article-title":"Cernunnos interacts with the XRCC4 \u00d7 DNA-ligase IV complex and is homologous to the yeast nonhomologous end-joining factor Nej1","volume":"281","author":"Callebaut","year":"2006","journal-title":"J Biol Chem"},{"key":"key20180107184800_b22-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"22148","DOI":"10.1074\/jbc.M102396200","article-title":"XRCC2 is a nuclear RAD51-like protein required for damage-dependent RAD51 focus formation without the need for ATP binding","volume":"276","author":"O\u2019Regan","year":"2001","journal-title":"J Biol Chem"},{"key":"key20180107184800_b23-ijo-41-02-0565","first-page":"635","article-title":"Beneficial effect of cepharanthine on overcoming drug-resistance of hepatocellular carcinoma","volume":"24","author":"Nakajima","year":"2004","journal-title":"Int J Oncol"},{"key":"key20180107184800_b24-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1349-7006.2005.00057.x","article-title":"Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells","volume":"96","author":"Ikeda","year":"2005","journal-title":"Cancer Sci"},{"key":"key20180107184800_b25-ijo-41-02-0565","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.febslet.2005.12.048","article-title":"Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH-7) through the activation of JNK1\/2 and the downregulation of Akt","volume":"580","author":"Biswas","year":"2006","journal-title":"FEBS Lett"},{"key":"key20180107184800_b26-ijo-41-02-0565","first-page":"807","article-title":"Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloid","volume":"33","author":"Kikukawa","year":"2008","journal-title":"Int J Oncol"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2012.1501\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T18:50:57Z","timestamp":1515351057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2012.1501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,31]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,5,31]]},"published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.3892\/ijo.2012.1501"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2012.1501","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,31]]}}}